Tourette syndrome is treated with a combination of behavioral therapy, medication, and management of related conditions like ADHD or OCD. No single treatment eliminates tics entirely, but the right approach can reduce their frequency and intensity enough to make daily life significantly easier. The good news: roughly three-quarters of children with Tourette syndrome see their tics greatly diminish by early adulthood, and over one-third become completely tic-free.
Behavioral Therapy Is the First-Line Treatment
The most effective non-drug treatment for tics is a type of therapy called Comprehensive Behavioral Intervention for Tics (CBIT). It combines three elements: learning to recognize the urge that precedes a tic, practicing a competing physical response that blocks it, and identifying the situations or triggers that make tics worse. The core technique, called habit reversal training, has been shown to reduce tic severity by about 55% in controlled studies.
Here’s what CBIT looks like in practice. A therapist helps you (or your child) notice the specific sensation that builds just before a tic happens. Then you learn a “competing response,” a deliberate movement or action that’s physically incompatible with the tic. If you have a head-jerking tic, for example, the competing response might involve gently tensing your neck muscles in a way that prevents the jerk. You hold that response until the urge passes. Sessions also include relaxation training and strategies for managing environments where tics tend to flare up, like stressful social situations or transitions between activities.
CBIT typically runs for about eight sessions over 10 weeks. It requires consistent practice between sessions, so motivation matters. For younger children, a parent or caregiver is usually involved. Other behavioral approaches, like relaxation training alone (about 32% tic reduction) or self-monitoring (44% reduction), can help but are generally less effective than the full CBIT protocol.
Medications for Moderate to Severe Tics
When tics are disruptive enough that behavioral therapy alone isn’t sufficient, medication becomes part of the plan. Three drugs are FDA-approved specifically for tic disorders: haloperidol, pimozide, and aripiprazole. All three work by blocking dopamine activity in the brain, which is closely linked to tic generation. They can meaningfully reduce tic severity, but they come with side effects like weight gain, drowsiness, and muscle stiffness that limit their use, especially in children.
Many doctors start with a different class of medication before reaching for dopamine blockers. Blood pressure medications originally designed for other purposes, specifically clonidine and guanfacine, are widely used off-label for tics. They’re generally better tolerated, particularly in kids. The most common side effect is drowsiness, which often improves after the first few weeks or with a dose adjustment. Dry mouth, dizziness, and mild drops in blood pressure can also occur. These medications tend to produce a more modest tic reduction than dopamine blockers, but their milder side-effect profile makes them a practical starting point.
Treating the Conditions That Come With It
Tics are often not the most disabling part of living with Tourette syndrome. About 85% of people with Tourette’s have at least one co-occurring condition, most commonly ADHD, OCD, anxiety, or mood disorders. Current treatment guidelines emphasize that whichever symptom causes the most impairment should be treated first.
This means that for a child whose ADHD is causing more problems at school than their tics, treating the attention difficulties takes priority. For someone whose obsessive-compulsive symptoms are more distressing than their motor tics, OCD-focused therapy and medication come first. The key consideration is choosing treatments that help one problem without worsening another. Clinicians screen for anxiety, mood disorders, and disruptive behavior alongside tic severity to build a treatment plan that addresses the full picture rather than just the tics in isolation.
Botulinum Toxin for Specific Tics
When a single tic is particularly bothersome or painful, targeted injections of botulinum toxin (the same substance used in cosmetic treatments) can temporarily weaken the muscles involved. This works best for focal motor tics affecting the face, neck, or shoulders. In one uncontrolled study of 35 people, motor tic improvement lasted an average of about 14 weeks per injection. One patient with severe neck-jerking tics described the treatment as “life changing.”
For vocal tics, the picture is less clear. A study of 30 people with vocal tics found improvement in 95% of participants, but the benefit lasted only about six days on average, making it impractical for ongoing management. Botulinum toxin is not a broad treatment for Tourette syndrome. It’s a targeted option for one or two tics that are causing the most distress or physical harm.
Deep Brain Stimulation for Severe Cases
Deep brain stimulation (DBS) is a surgical option reserved for people with severe, treatment-resistant Tourette syndrome. It involves implanting thin electrodes in specific areas of the brain that help regulate movement, connected to a small battery-powered device under the skin of the chest. The device delivers continuous electrical pulses that can reduce tic severity.
The eligibility bar is high. Candidates must have tried and failed medications from at least three different drug classes, including a blood pressure medication, two different dopamine blockers, and at least one additional type. Behavioral therapy like CBIT should also have been attempted. Tics need to be the most disabling symptom, and any co-occurring psychiatric conditions must be stable and under treatment for at least six months. While age isn’t a strict cutoff, DBS in patients under 18 requires ethical review. This is a last-resort intervention for the small percentage of people whose tics remain severe despite exhausting other options.
Cannabis-Based Treatments
Interest in cannabis for Tourette syndrome has grown, but the evidence remains thin. Only two small randomized controlled trials have been completed, both at a single research center, using THC capsules. They showed modest improvements in tic frequency and severity. A single case study using a THC-CBD spray reported an 85% reduction in tics over four weeks, but one case is far from proof.
Several larger observational studies have reported that some people with Tourette’s notice their tics improve with cannabis use, but these are self-reported and uncontrolled. The research is not yet strong enough to make cannabis a standard recommendation, and it carries its own risks, particularly for adolescents whose brains are still developing.
The Long-Term Picture
Tourette syndrome is not a lifelong sentence of severe tics for most people. Tics typically peak in severity between ages 10 and 12, then gradually improve through adolescence. By early adulthood, more than three-quarters of people who had significant tics as children will experience substantially fewer or milder tics. Over one-third become completely tic-free. Less than a quarter continue to have moderate or greater tic severity into adulthood.
This natural trajectory means that treatment intensity can often be reduced over time. A child who needs medication and regular CBIT sessions at age 11 may need little or no treatment by their early twenties. For the minority whose tics persist into adulthood, the same treatment options remain available, and many adults find that the coping strategies they learned through behavioral therapy continue to be useful even without formal sessions.